Entities / Company
Dexcom.
company that develops, manufactures and distributes continuous glucose monitoring systems
- Reports this week
- 0
- Active events
- 1
- Connections
- 113
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
TD Cowen issued a buy rating and price target for Dexcom on October 9, 2026.Some support1 report
-
Tandem Mobi utilizes Dexcom G7 technology for monitoring.Some support1 report
-
Oura announces partnerships with Dexcom and Resmed for health feature integration, while noting that regulatory uncertainty affects its product scope.Some support1 report
-
Dexcom and Dentsply Sirona are identified as healthcare companies operating within the same sector.Some support1 report
One to three months ago
-
Dexcom stock received a raised price objective and rating restatement from analysts, accompanied by SEC filings.Some support1 report
-
The Ohio retirement system purchased a new stake in Dexcom on August 31, 2026.Some support1 report
-
Norges Bank bought a new stake in Dexcom and Geode Capital Management increased its stake on August 30, 2026.Some support1 report
-
Gilead Sciences, Boston Scientific, McKesson Corporation, and Dexcom are listed as top medical stocks.Some support3 reports
-
Dexcom received a rating and price target report from Raymond James Financial while trading on Nasdaq.Some support3 reports
-
Baxter International, Insulet Corporation, and Dexcom compete in the healthcare equipment market.Some support1 report
-
Market analysis comparing the financial performance and risk profiles of Dexcom and Nuwellis has been published.Some support1 report
-
CMS proposed payment reductions impacting diabetes care.Speculative1 report1 development inside
-
Dexcom submitted positive CONNECT trial results to CMS.Some support1 report
-
Dexcom launched its Flex sensor in the market and is currently seeking international regulatory clearance for the product.Some support1 report
-
Norges Bank acquired a new position in Dexcom stock on July 29, 2026.Some support1 report
Gone quiet
No new reports in 90+ days-
Fifth Third Bancorp increased its stake in Dexcom by 206.0% in Q1, requiring SEC disclosure.Some support1 report
-
Institutional investors are tracking Dexcom stock.Some support1 report
-
Dexcom G7 receives Health Canada authorization and integrates with Apple Watch for data viewing.Some support1 report
-
Bell Global Equities Fund highlighted Dexcom as a notable outperformer on July 9, 2026.Some support2 reports
-
FDA approval allows market entry for devices from Dexcom and Intuitive Surgical.Some support2 reports
-
Edgepark offered Dexcom its Stelo biosensor on July 15, 2025.Some support2 reports
-
Dexcom received oversight from the FDA regarding the approval of its systems on August 19, 2025.Well supported3 reports
-
Analyst firms, including Citigroup and William Blair, have issued ratings and price targets for Dexcom.Some support1 report
-
Dexcom made required institutional filings with the SEC on June 16, 2026.Some support1 report
-
Dexcom saw multiple analyst rating updates, stock sales, and new coverage from firms like Truist, Bank of America, and Benchmark.Some support3 reports
-
Dexcom filed required disclosures regarding investor activity with the Securities and Exchange Commission on June 6, 2026.Some support1 report
-
Dexcom, Roche, and Exact Sciences were cited as industry leaders innovating aggressively in POC solutions.Some support1 report
-
Abbott is developing a dual-analyte sensor while Dexcom's CFO discusses earnings.Some support1 report
-
HHS wearables campaign promotes glucose monitors.Speculative2 reports
-
Dexcom executives, including Jeff Johnson, faced questioning from analysts like UBS and Raymond James regarding gross margins, international performance in markets like France and Japan, and resilience during a downturn.Speculative1 report
-
Sean Christensen was appointed VP of Finance and IR at Dexcom.Some support2 reports
-
Medicare spending cuts are affecting diabetes device companies like Insulet and Dexcom.Speculative2 reports1 development inside
-
Robert F. Kennedy Jr. discussed the MAHA push with Congress, involving companies like Dexcom and Abbott Laboratories.Speculative1 report1 development inside
-
Kennedy Jr. touted CGMs at a Congressional hearing, coinciding with FDA clearances for Dexcom and Abbott devices.Speculative1 report
-
Airbnb was co-founded in San Francisco, and Dexcom received FDA approval for its systems.Speculative1 report
-
Bayer Aktiengesellschaft and Dexcom were classified within the Large Cap Pharmaceuticals and Medical sectors, with Dexcom showing strong performance.Speculative1 report1 development inside
-
Dexcom hosted a Signing Day Camp in Baltimore, welcoming athletes like Miles Byrd and featuring Mark Andrews.Some support1 report
-
Trade policies related to Donald Trump caused broader market volatility, involving Dexcom.Some support1 report
-
Dexcom and Amarin were reported to be outperforming their respective sectors on July 21, 2025.Some support1 report
-
Facts established on August 27, 2025, include Simon Glass as CEO of Discuss, and that Mastercard, Dexcom, and Suntory are trusted global brands.Some support2 reports
-
Freshpet markets products across Europe, while Dexcom operates within the US market, supported by general market momentum.Some support1 report
-
UBS and other analysts highlighted several companies, including Dexcom, Abbott Laboratories, Boeing, Eli Lilly, and Capital One, as preferred stocks or top picks on July 31, 2025.Some support1 report
-
Fierce competition from Abbott Laboratories regarding Dexcom products.Some support1 report1 development inside
-
Dexcom reported on July 31, 2025, that its international revenues improved by 16% year over year.Some support1 report
-
Dexcom announced partnerships with Oura for compatibility, new direct-to-watch connectivity, and named Jake Leach as its new CEO.Some support2 reports
-
Goldman Sachs expressed bullish sentiment regarding Dexcom, driven by U.S. growth expectations.Some support1 report
-
Diabeloop and ViCentra announced a partnership to launch a new system combining with Dexcom G7 in the Netherlands.Some support1 report
-
Market analysis suggests that urban centers, including those in Saudi Arabia, hold significant potential for market growth, particularly in the area of diabetes care, driven by increasing incidence rates.Some support1 report
-
Bank of America analysts questioned Dexcom's raised guidance, which was overseen by CFO Sylvain, as of August 13, 2025.Some support1 report
-
Dexcom CGM data has been integrated into the FriskaAi platform.Some support2 reports
-
Dexcom received its first FDA approval in 2006.Some support5 reports
-
Trinity Biotech's CGM+ aims to lower costs.Some support1 report
-
Signos received FDA clearance for its glucose monitoring system, which integrates the Stelo biosensor from Dexcom.Some support1 report
-
Partnership between Dexcom, Amazon, and Oura regarding FDA clearance for a 15-day G7 sensor.Some support1 report
-
Old National Bank offers services in the U.S., and Dexcom operates within the U.S. stock market.Some support2 reports
-
Dexcom, a glucose-monitoring company, shifted its manufacturing operations to centralize in Arizona.Some support1 report
-
A product issue affecting Dexcom products has been reported, impacting the U.S. market since May 27, 2026.Some support1 report1 development inside
-
Argus received coverage from Argus with a Buy rating on August 31, 2025.Some support2 reports
-
Aging population is driving increased demand for medical treatments from companies like AbbVie, Amgen, and Dexcom.Some support2 reports
No events began in the chosen period. Widen it, or reset.
What's reaching Dexcom
Events traced to Dexcom, step by step, newest firstAround Dexcom this week
News at the entities that move Dexcom most-
FDA StructuralAbbott Laboratories faces an FDA recall classification of its sensors, while Ken Fisher and Donald Trump engage in stock transactions.Moves Dexcom
-
Health Canada StructuralHealth Canada approved revyve Antimicrobial Wound Gel, a product developed by a company, for use.Moves Dexcom
-
SEC StructuralSEC filing reported ETF holdings involving SPX on October 19, 2026.Moves Dexcom
-
CMS StructuralCMS finalized Medicare changes for 2027, noting that Medicare cost limits are outpacing Social Security COLA increases.Moves Dexcom
-
Nasdaq StructuralCoinbase announced its listing on Nasdaq, expanded its use of the Base blockchain for settlement, and is deepening its partnership with Marqeta.Moves Dexcom
-
Fifth Third Bancorp TransactionalFifth Third Bancorp expanded its retail deposit share and ran marketing campaigns in southern markets.Moves Dexcom
Connections
The 40 strongest of 113, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
FDA formally regulates Dexcom's manufacturing processes and grants market clearance for its medical devices.
-
CMS Structural
CMS regulates payment structures and coverage decisions for Dexcom's continuous glucose monitor products.
-
Amazon Operational
Dexcom leverages Amazon's massive e-commerce platform and distribution network to expand the market reach of its Stelo sensor products.
-
Tandem Diabetes Care, Inc. Structural
Tandem's medical device product relies functionally on Dexcom's continuous glucose monitoring technology.
-
SEC Structural
Dexcom is subject to formal regulatory oversight by the SEC, requiring specific financial and transaction disclosures.
-
Nasdaq Structural
Dexcom is a publicly traded company listed on the Nasdaq stock exchange.
-
Fifth Third Bancorp Transactional
Fifth Third Bancorp significantly increased its investment stake in Dexcom by 206.0% in Q1 2026.
-
Abbott Japan Operational
Abbott Japan and Dexcom are direct competitors in the continuous glucose monitoring (CGM) market, actively vying for market share and technological leadership.
Show all 40 connections
-
Apple Watch Operational
Dexcom leverages the Apple Watch platform for integrated display and viewing of its health data.
-
Abbott Laboratories Operational
Dexcom and Abbott Laboratories are fierce competitors operating within the glucose monitoring market.
-
Health Canada Structural
Health Canada authorizes and regulates Dexcom's medical devices, establishing a formal dependency for market access.
-
Tandem Structural
Dexcom's product is functionally integrated with Tandem's systems.
-
Ohio Transactional
Ohio's retirement system purchased a new stake in Dexcom.
-
Oura Operational
Dexcom and Oura maintain a partnership focused on enhancing digital integration and health feature compatibility between their products.
-
William P. Blair Transactional
William P. Blair issued a strong buy recommendation regarding Dexcom's company shares.
-
Insulet (United States) Operational
The companies actively compete in the patient monitoring sector while also achieving functional integration between their respective products.
-
Raymond James Financial Mentioned together
Raymond James Financial influences Dexcom's market state through the issuance of financial ratings and price target reports.
-
Norges Bank Transactional
Norges Bank acquired a new financial stake in Dexcom stock.
-
Connect Transactional
The Connect clinical trial successfully demonstrated A1C improvement, providing positive data for Dexcom's product line.
-
Securities and Exchange Commission Structural
Dexcom is subject to SEC requirements regarding the filing of investor activity and stock transactions.
-
Bank of America Operational
Bank of America analysts actively scrutinize Dexcom's guidance and have adjusted their target price based on their analysis.
-
TD Cowen Mentioned together
TD Cowen provides market ratings and coverage on Dexcom shares.
-
Ireland Operational
Dexcom is actively hiring for a manufacturing facility located in Ireland.
-
Medicare Structural
Dexcom's product trial results support Medicare reimbursement, establishing a structural dependency on the payment system.
-
Donald Trump Operational
Dexcom's market performance and outlook are influenced by Donald Trump's trade policies and tariffs.
-
Citigroup Mentioned together
Citigroup provides financial analysis, including price targets and buy ratings, for Dexcom shares.
-
Dentsply Sirona Operational
The two companies are identified as competitors operating within the same healthcare sector.
-
Geode Capital Management Transactional
Geode Capital Management increased its investment stake in Dexcom.
-
Baxter International Operational
Both Dexcom and Baxter International are identified as peers competing within the healthcare equipment segment.
-
MarketBeat Mentioned together
MarketBeat provides financial ratings and price targets for Dexcom.
-
Europe Shared context
Dexcom operates and reports international revenues within the European market.
-
Resmed Mentioned together
Both companies are grouped thematically within the healthcare equipment segment.
-
Royal Bank of Canada Transactional
RBC is evaluating Dexcom's stock through price target raises and formal reviews.
-
San Diego Shared context
Dexcom is a medical device company headquartered and based in San Diego, California.
-
Apple Inc. Operational
Dexcom's application is scheduled to roll out on the Apple iPhone platform.
-
Truist Financial Mentioned together
Truist Financial has provided buy ratings and price objectives for Dexcom.
-
Benchmark Mentioned together
Benchmark provides financial coverage and tracking of Dexcom's stock shares.
-
Jon Coleman Transactional
Jon Coleman sold Dexcom stock shares in a specific financial transaction.
-
Goldman Sachs Mentioned together
Goldman Sachs provided investment coverage and expressed bullish sentiment regarding Dexcom.
-
Gilead Sciences Mentioned together
Both Dexcom and Gilead Sciences are listed together as top medical stocks.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
4 events- Tandem Mobi utilizes Dexcom G7 technology for monitoring.
- Oura announces partnerships with Dexcom and Resmed for health feature integration, while noting that regulatory uncertainty affects its product scope.
- Dexcom and Dentsply Sirona are identified as healthcare companies operating within the same sector.
- Dexcom stock received a raised price objective and rating restatement from analysts, accompanied by SEC filings.
August 2026
6 events- The Ohio retirement system purchased a new stake in Dexcom on August 31, 2026.
- Norges Bank bought a new stake in Dexcom and Geode Capital Management increased its stake on August 30, 2026.
- Gilead Sciences, Boston Scientific, McKesson Corporation, and Dexcom are listed as top medical stocks.
- Baxter International, Insulet Corporation, and Dexcom compete in the healthcare equipment market.
- Market analysis comparing the financial performance and risk profiles of Dexcom and Nuwellis has been published.
- Dexcom submitted positive CONNECT trial results to CMS.
Show 2 earlier months
July 2026
7 events- Dexcom launched its Flex sensor in the market and is currently seeking international regulatory clearance for the product.
- Norges Bank acquired a new position in Dexcom stock on July 29, 2026.
- Fifth Third Bancorp increased its stake in Dexcom by 206.0% in Q1, requiring SEC disclosure.
- Institutional investors are tracking Dexcom stock.
- Dexcom G7 receives Health Canada authorization and integrates with Apple Watch for data viewing.
- Bell Global Equities Fund highlighted Dexcom as a notable outperformer on July 9, 2026.
- FDA approval allows market entry for devices from Dexcom and Intuitive Surgical.
June 2026
42 events- Garmin hosts the Marathon Series, which is supported by Brooks Running and Dexcom, who have presence at the event.
- Dexcom received a rating and price target report from Raymond James Financial while trading on Nasdaq.
- CMS proposed payment reductions impacting diabetes care.
- Edgepark offered Dexcom its Stelo biosensor on July 15, 2025.
- Dexcom received oversight from the FDA regarding the approval of its systems on August 19, 2025.
- Analyst firms, including Citigroup and William Blair, have issued ratings and price targets for Dexcom.
- Dexcom made required institutional filings with the SEC on June 16, 2026.
- Dexcom saw multiple analyst rating updates, stock sales, and new coverage from firms like Truist, Bank of America, and Benchmark.
- Dexcom filed required disclosures regarding investor activity with the Securities and Exchange Commission on June 6, 2026.
- Dexcom, Roche, and Exact Sciences were cited as industry leaders innovating aggressively in POC solutions.
- Abbott is developing a dual-analyte sensor while Dexcom's CFO discusses earnings.
- HHS wearables campaign promotes glucose monitors.
- Dexcom executives, including Jeff Johnson, faced questioning from analysts like UBS and Raymond James regarding gross margins, international performance in markets like France and Japan, and resilience during a downturn.
- Sean Christensen was appointed VP of Finance and IR at Dexcom.
- Medicare spending cuts are affecting diabetes device companies like Insulet and Dexcom.
- Robert F. Kennedy Jr. discussed the MAHA push with Congress, involving companies like Dexcom and Abbott Laboratories.
- Kennedy Jr. touted CGMs at a Congressional hearing, coinciding with FDA clearances for Dexcom and Abbott devices.
- Airbnb was co-founded in San Francisco, and Dexcom received FDA approval for its systems.
- Bayer Aktiengesellschaft and Dexcom were classified within the Large Cap Pharmaceuticals and Medical sectors, with Dexcom showing strong performance.
- Dexcom hosted a Signing Day Camp in Baltimore, welcoming athletes like Miles Byrd and featuring Mark Andrews.
- Trade policies related to Donald Trump caused broader market volatility, involving Dexcom.
- Dexcom and Amarin were reported to be outperforming their respective sectors on July 21, 2025.
- Facts established on August 27, 2025, include Simon Glass as CEO of Discuss, and that Mastercard, Dexcom, and Suntory are trusted global brands.
- Freshpet markets products across Europe, while Dexcom operates within the US market, supported by general market momentum.
- UBS and other analysts highlighted several companies, including Dexcom, Abbott Laboratories, Boeing, Eli Lilly, and Capital One, as preferred stocks or top picks on July 31, 2025.
- Fierce competition from Abbott Laboratories regarding Dexcom products.
- Dexcom reported on July 31, 2025, that its international revenues improved by 16% year over year.
- Dexcom announced partnerships with Oura for compatibility, new direct-to-watch connectivity, and named Jake Leach as its new CEO.
- Goldman Sachs expressed bullish sentiment regarding Dexcom, driven by U.S. growth expectations.
- Diabeloop and ViCentra announced a partnership to launch a new system combining with Dexcom G7 in the Netherlands.
- Market analysis suggests that urban centers, including those in Saudi Arabia, hold significant potential for market growth, particularly in the area of diabetes care, driven by increasing incidence rates.
- Bank of America analysts questioned Dexcom's raised guidance, which was overseen by CFO Sylvain, as of August 13, 2025.
- Dexcom CGM data has been integrated into the FriskaAi platform.
- Dexcom received its first FDA approval in 2006.
- Trinity Biotech's CGM+ aims to lower costs.
- Signos received FDA clearance for its glucose monitoring system, which integrates the Stelo biosensor from Dexcom.
- Partnership between Dexcom, Amazon, and Oura regarding FDA clearance for a 15-day G7 sensor.
- Old National Bank offers services in the U.S., and Dexcom operates within the U.S. stock market.
- Dexcom, a glucose-monitoring company, shifted its manufacturing operations to centralize in Arizona.
- A product issue affecting Dexcom products has been reported, impacting the U.S. market since May 27, 2026.
- Argus received coverage from Argus with a Buy rating on August 31, 2025.
- Aging population is driving increased demand for medical treatments from companies like AbbVie, Amgen, and Dexcom.